JPRN-UMIN000003359已完成4 期
Evaluation of renal protection by irbesartan and losartan in renal transplanted patients - I-LORD study
Kanazawa Medical University School of Medicine, Division of Nephrology0 个研究点目标入组 140 人开始时间: 2010年4月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •renal failure (serum creatinine more than 2.5mg/dL) Child bearing women
研究者
相似试验
已完成
3 期
Evaluation of Renal Protection by Impidapril and Irbesartan in Patients with Essential HypertensioEssential HypertensionJPRN-UMIN000002430Medicine and Bioregulatory Sciences40
尚未招募
不适用
Irbesartan Antihypertensive effect on Kidney and HeartHypertensionJPRN-UMIN000002944The University of Tokushima hospital200
已完成
4 期
Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent MicroalbuminuriaMicroalbuminuriaType 2 DiabetesNCT00320879Steno Diabetes Center Copenhagen52
已完成
不适用
Influence of Olmesartan and azelnidipine on renal function during cardiac surgerymyocardial infarction, angina, aortic dessection, valve diseaseJPRN-UMIN000001637ihon University Itabashi Hospital100
招募中
不适用
Study of the renal protective effect of tolvaptan as a replacement of loop diuretics for the treatment of ascites in cirrhotic patients with renal dysfunctioliver cirrhosisJPRN-UMIN000044693Tohoku Medical and Pharmaceutical University15